{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T06:19:29Z","timestamp":1788848369260,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National Key Basic\u00a0Research Program in China","award":["2010CB529800"],"award-info":[{"award-number":["2010CB529800"]}]},{"name":"National Key Basic\u00a0Research Program in China","award":["2010CB530100"],"award-info":[{"award-number":["2010CB530100"]}]},{"name":"China Specific Project for Developing New Drugs","award":["2011ZX09401-302"],"award-info":[{"award-number":["2011ZX09401-302"]}]},{"name":"Fundamental Research Funds for the Central Universities in China"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.biomaterials.2013.01.075","type":"journal-article","created":{"date-parts":[[2013,2,13]],"date-time":"2013-02-13T10:31:12Z","timestamp":1360751472000},"page":"3511-3522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus"],"prefix":"10.1016","volume":"34","author":[{"given":"Wei","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawen","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingliang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijian","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2013.01.075_bib1","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/mas.20340","article-title":"Peptide and protein drugs: the study of their metabolism and catabolism by mass spectrometry","volume":"31","author":"Katsila","year":"2012","journal-title":"Mass Spectrom Rev"},{"key":"10.1016\/j.biomaterials.2013.01.075_bib2","doi-asserted-by":"crossref","first-page":"609","DOI":"10.4155\/tde.12.37","article-title":"Peptides for cancer therapy: a drug-development opportunity and a drug-delivery challenge","volume":"3","author":"Bidwell","year":"2012","journal-title":"Ther Deliv"},{"key":"10.1016\/j.biomaterials.2013.01.075_bib3","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.4155\/fmc.12.94","article-title":"Therapeutic peptides","volume":"4","author":"Albericio","year":"2012","journal-title":"Future Med Chem"},{"key":"10.1016\/j.biomaterials.2013.01.075_bib4","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.biomaterials.2012.08.070","article-title":"Airway delivery of peptides and proteins using nanoparticles","volume":"34","author":"Dombu","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2013.01.075_bib5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.drudis.2009.10.009","article-title":"Synthetic therapeutic peptides: science and market","volume":"15","author":"Vlieghe","year":"2010","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.biomaterials.2013.01.075_bib6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1348-0421.2000.tb02485.x","article-title":"Inhibition of HIV-1 infection by an intramolecular antisense peptide to T20 in gp160","volume":"44","author":"Imai","year":"2000","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.biomaterials.2013.01.075_bib7","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1086\/381707","article-title":"Short-term safety and antiretroviral activity of T-1249, a second-generation fusion inhibitor of HIV","volume":"189","author":"Eron","year":"2004","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.biomaterials.2013.01.075_bib8","doi-asserted-by":"crossref","first-page":"151854","DOI":"10.1155\/2012\/151854","article-title":"Molecular dynamics simulation of HIV fusion inhibitor T-1249: insights on peptide\u2013lipid interaction","volume":"2012","author":"Martins do Canto","year":"2012","journal-title":"Comput Math Methods Med"},{"key":"10.1016\/j.biomaterials.2013.01.075_bib9","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1073\/pnas.0712380105","article-title":"A\u00a0virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in\u00a0vitro","volume":"105","author":"Cheng","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biomaterials.2013.01.075_bib10","doi-asserted-by":"crossref","first-page":"14318","DOI":"10.1128\/JVI.79.22.14318-14329.2005","article-title":"Human beta-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection","volume":"79","author":"Sun","year":"2005","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.biomaterials.2013.01.075_bib11","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1128\/AAC.43.6.1317","article-title":"Peptide antibiotics","volume":"43","author":"Hancock","year":"1999","journal-title":"Antimicrobial Agents Chemother"},{"key":"10.1016\/j.biomaterials.2013.01.075_bib12","doi-asserted-by":"crossref","first-page":"D933","DOI":"10.1093\/nar\/gkn823","article-title":"APD2: the updated antimicrobial peptide database and its application in peptide design","volume":"37","author":"Wang","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.biomaterials.2013.01.075_bib13","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1128\/AAC.00495-10","article-title":"The virucidal EB peptide protects host cells from herpes simplex virus type 1 infection in the presence of serum albumin and aggregates proteins in a detergent-like manner","volume":"54","author":"Bultmann","year":"2010","journal-title":"Antimicrobial Agents Chemother"},{"key":"10.1016\/j.biomaterials.2013.01.075_bib14","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.2174\/138161209788682325","article-title":"The roles of antimicrobial peptides in innate host defense","volume":"15","author":"Diamond","year":"2009","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.biomaterials.2013.01.075_bib15","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.peptides.2011.05.015","article-title":"Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses","volume":"32","author":"Li","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.biomaterials.2013.01.075_bib16","doi-asserted-by":"crossref","first-page":"30181","DOI":"10.1074\/jbc.M112.370312","article-title":"Mucroporin-M1 inhibits hepatitis B virus replication by activating the mitogen-activated protein kinase (MAPK) pathway and down-regulating HNF4alpha in\u00a0vitro and in\u00a0vivo","volume":"287","author":"Zhao","year":"2012","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biomaterials.2013.01.075_bib17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.peptides.2010.10.008","article-title":"A\u00a0new natural alpha-helical peptide from the venom of the scorpion Heterometrus petersii kills HCV","volume":"32","author":"Yan","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.biomaterials.2013.01.075_bib18","doi-asserted-by":"crossref","first-page":"e34947","DOI":"10.1371\/journal.pone.0034947","article-title":"Anti-HIV-1 activity of a new scorpion venom peptide derivative Kn2-7","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biomaterials.2013.01.075_bib19","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1268","article-title":"Production of infectious hepatitis C virus in tissue culture from a cloned viral genome","volume":"11","author":"Wakita","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.biomaterials.2013.01.075_bib20","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1073\/pnas.0337677100","article-title":"Histidine-rich amphipathic peptide antibiotics promote efficient delivery of DNA into mammalian cells","volume":"100","author":"Kichler","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biomaterials.2013.01.075_bib21","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0005-2736(99)00219-9","article-title":"Calcium enhances the transfection potency of plasmid DNA-cationic liposome complexes","volume":"1463","author":"Lam","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.biomaterials.2013.01.075_bib22","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.chembiol.2005.06.009","article-title":"Calcium ions effectively enhance the effect of antisense peptide nucleic acids conjugated to cationic tat and oligoarginine peptides","volume":"12","author":"Shiraishi","year":"2005","journal-title":"Chem Biol"},{"key":"10.1016\/j.biomaterials.2013.01.075_bib23","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1248\/cpb.59.202","article-title":"A\u00a0novel, bio-reducible gene vector containing arginine and histidine enhances gene transfection and expression of plasmid DNA","volume":"59","author":"Tanaka","year":"2011","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"10.1016\/j.biomaterials.2013.01.075_bib24","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.bbamem.2010.09.001","article-title":"Happy birthday cell penetrating peptides: already 20 years","volume":"1798","author":"Brasseur","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.biomaterials.2013.01.075_bib25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jconrel.2011.11.024","article-title":"Effective endogenous gene silencing mediated by pH responsive peptides proceeds via multiple pathways","volume":"158","author":"Lam","year":"2012","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2013.01.075_bib26","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1476-5381.2009.00057.x","article-title":"Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics","volume":"157","author":"Heitz","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.biomaterials.2013.01.075_bib27","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.addr.2004.12.001","article-title":"Tat peptide-mediated cellular delivery: back to basics","volume":"57","author":"Brooks","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.biomaterials.2013.01.075_bib28","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.addr.2010.05.003","article-title":"Cell penetrating elastin-like polypeptides for therapeutic peptide delivery","volume":"62","author":"Bidwell","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.biomaterials.2013.01.075_bib29","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1007\/s11095-010-0138-2","article-title":"Design and evaluation of histidine-rich amphipathic peptides for siRNA delivery","volume":"27","author":"Langlet-Bertin","year":"2010","journal-title":"Pharm Res"},{"key":"10.1016\/j.biomaterials.2013.01.075_bib30","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1042\/BJ20101021","article-title":"Effective siRNA delivery and target mRNA degradation using an amphipathic peptide to facilitate pH-dependent endosomal escape","volume":"435","author":"Bartz","year":"2011","journal-title":"Biochem J"},{"key":"10.1016\/j.biomaterials.2013.01.075_bib31","doi-asserted-by":"crossref","first-page":"9294","DOI":"10.1073\/pnas.0503596102","article-title":"Robust hepatitis C virus infection in\u00a0vitro","volume":"102","author":"Zhong","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biomaterials.2013.01.075_bib32","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jconrel.2006.12.004","article-title":"Optimising histidine rich peptides for efficient DNA delivery in the presence of serum","volume":"118","author":"Mason","year":"2007","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2013.01.075_bib33","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jconrel.2010.11.004","article-title":"Endosomal escape pathways for delivery of biologicals","volume":"151","author":"Varkouhi","year":"2011","journal-title":"J\u00a0Control Release"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961213001166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961213001166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T15:47:09Z","timestamp":1758901629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961213001166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":33,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0142961213001166"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2013.01.075","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2013.01.075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}